CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM NEW
Total 13F shares
203,379
Share change
+203,379
Total reported value
$720,132
Price per share
$3.58
Number of holders
12
Value change
+$720,132
Number of buys
12

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q1 2015

As of 31 Mar 2015, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 203,379 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, LADENBURG THALMANN FINANCIAL SERVICES INC, DEUTSCHE BANK AG\, KCG Holdings, Inc., BlackRock Advisors LLC, Winfield Associates, Inc., UBS Group AG, WELLS FARGO & COMPANY/MN, and Tower Research Capital LLC (TRC). This page lists 12 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.